In B-acute lymphoblastic leukemia, a cancer that originates from a B-cell precursor lineage and is particularly common among pediatric patients, high TERT levels and telomerase activity correlate with poor clinical outcomes and lower survival rates [69,70,71,72]. This evidence concerns the gene TERT and cancer.